Official UK procurement notice
NP90722m Brodalumab (Kyntheum®) · UK public procurement notice
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)
What is being bought
Published requirement descriptionSupply of Brodalumab (Kyntheum®) to NHS Scotland
CPV: Pharmaceutical products
The lotProcurement structure
single lot · no lot value publishedLot #1Supply of Brodalumab (Kyntheum®) pre-filled syringes to NHS ScotlandCancelled
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (1)
- as per procurement docs: 100%
Published award criteria (2)
- as per procurement docs: 100
- Price: 0
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Cancelled
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 6 Apr 2023, 14:47 BST
- Last source update
- 6 Apr 2023, 14:47 BST
- FTS notice number
2023/S 000-010192- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03bd5fFind a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights
- Published justification
The medicine awarded to this framework agreement is, and will remain to be, protected by patent for the duration of the framework agreement.
- Review procedure
The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the authority despatches the VEAT notice and the date on which the authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer. The bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
Publisher note: The total value in Sections II.1.7 and V.2.4 refers to the twenty-four (24) months initial period and twenty-four (24) months extension period. (SC Ref:728609)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast1 further award records carry no date or value.
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Edinburgh Sheriff CourtReview body
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.